medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2013, Number 2

<< Back

Salud Mental 2013; 36 (2)

Funcionamiento cognoscitivo en la diabetes tipo 2: una revisión

Cerezo HK, Yáñez TG, Aguilar SCA, Mancilla DJM, Cerezo HK, Yáñez TG, Aguilar SCA, Mancilla DJM

Language: Spanish
References: 50
Page: 167-175
PDF size: 245.53 Kb.


ABSTRACT

The aim of this work is to offer an updated review of the major cognitive difficulties that appear in Type 2 Diabetes Mellitus (T2DM), and its association with the patient compliance related factors proposed by the Panamerican Health Organization (PAHO), such as characteristics of patient, of the disease and of treatment.
The review included electronic databases search (PubMed, PsycINFO and SpringerLink) from January 2000 to December 2011, predominating research from the United States, Canada, Holland, UK, Japan, Mexico and Germany.
Most of the reviewed articles identified that factors which have shown to be associated with cognitive functioning in T2DM include: glycemic fluctuations, disease duration and pharmacological treatment. As for the changes that occur in the Central Nervous System (CNS), to date there is no consensus as to whether these are purely degenerative, vascular or a combination of both.
Most affected cognitive abilities are: verbal memory, working memory, verbal fluency, attention, mental planning and psychomotor speed. The latter have been related with frontal, temporal and hyppocampal structure functioning, which are also compromised on T2DM. In the cognitive aspect, it is reported that T2DM is a risk factor for developing mild cognitive impairment. Also, chronicity of this condition associated with hypertension, inadequate glycemic control, and macrovascular complications increases the odds for vascular dementia to occur.
It is concluded that even though some risk factors of the cognitive deficiencies have been identified on T2DM, it is important to determine how they interact, and to what degree they affect overall cognitive performance, and specific functions in this population.


REFERENCES

  1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31:62-67.

  2. Organización Mundial de la Salud. Estadísticas de la prevalencia de diabetes a nivel mundial. Recuperado en octubre de 2011 http://www. who.int/mediacentre/factsheets/fs312/en/index.html

  3. Secretaria de Salud. Numeralia 2008: Diabetes mellitus. Diabetes Hoy 2009;10:2166-2178.

  4. Organización Panamericana de la Salud. Adherencia a los tratamientos a largo plazo; pruebas para la acción. Ginebra: OMS; 2004; pp. 1-39, 75-90.

  5. Watari K, Letamendi A, Elderkin-Thompson V, Harron E et al. Cognitive function in adults with type 2 diabetes and major depression. Arch Clin Neuropsychol 2006;21:787-796.

  6. Munshi M, Grande L, Hayes M, Ayres D et al. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 2006;29:1794-1799.

  7. Ishizawa L, Kumano H, Sato H, Iwamoto Y. Decreased response inhibition in middle-aged male patients with type 2 diabetes. Biopsychoso Med 2010;4:1-10.

  8. Shimada H, Miki T, Tamura A, Ataka S et al. Neuropsychological status of elderly patients with diabetes mellitus. Diabetes Res Clin Pract 2010;87:224-227.

  9. Grober E, Hall Ch, Hahn S, Lipton R. Memory impairment and executive dysfunction are associated with inadequately controlled diabetes in older adults. J Prim Care Community Health 2011;2:229-233.

  10. Roberts R, Geda Y, Knopman D, Christianson T et al. Duration and severity of diabetes are associated with mild cognitive impairment. Arch Neurol 2008;65:1066-1073.

  11. Iype T, Shaji S, Balakrishnan A, Charles D et al. Cognition in type 2 diabetes: association with vascular risk factors, complications of diabetes and depression. Ann Indian Acad Neurol 2009;12:25-27.

  12. Hewer W, Mussell M, Rist F, Kulzer B et al. Short-term effects of improved glycemic control on cognitive function in patients with type 2 diabetes. Gerontology 2003;49:86-92.

  13. Rosen M, Beauvais J, Rigsby M, Salahi J et al. Neuropsychological correlates of suboptimal adherence to metformin. J Behav Med 2003;4:349-360.

  14. Shorr R, de Rekeneire N, Resnick H, Yaffe K et al. Glycemia and cognitive function in older adults using glucose-lowering drugs. J Nutr Health Aging 2006;10:297-301.

  15. Ryan Ch, Freed M, Rood J, Cobitz A et al. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 2006;29:345-351.

  16. Den Heijer T, Vermeer S, Van Dijk E, Prins N et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 2003;46:1604-1610.

  17. Manshot S, Brands A, van der Grond J, Kessels R et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006;55:1106-1113.

  18. Brands A, Biessels G, Kappelle L, De Haan E et al. Cognitive functioning and brain MRI in patients with type 1 and 2 diabetes mellitus: a comparative study. Dement Geriatr Cogn Dis 2007;23:343-350.

  19. Hayashi K, Kurioka S, Yamaguchi T, Morita M et al. Association of cognitive dysfunction with hippocampal atrophy in elderly japanese patients with type 2 diabetes. Diabetes Res Clin Pract 2011;94:180-185.

  20. Zhao W, Alkon D. Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 2011;177:125-134.

  21. Manschot S, Biessels G, de Valk H, Algra A et al. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 2007;50:2388-2397.

  22. Cukierman T, Gerstein H, Williamson J. Cognitive decline and dementia in diabetes a systematic overview of prospective observational studies. Diabetologia 2005;42:2460-2469.

  23. Rajeev K, Jeffrey C, Looi L. Type 2 diabetes mellitus, cognition and brain in aging: A brief review. Indian J Psychiatry 2009;51:35-38.

  24. Luchsinger J, Reitz C, Patel B, Tang M et al. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007:64:570-575.

  25. Mejía-Arango S, Miguel-Jaimes A, Villa A, Ruiz-Arregui L et al. Deterioro cognoscitivo y factores asociados en adultos mayores en México. Salud Pública Mex 2007;49:475-480.

  26. Yaffe K, Kanaya A, Lindquist K, Simonsick E et al. The metabolic síndrome, inflammation, and risk of cognitive decline. J Am Med Assoc 2004;292:2237-2242.

  27. Cervantes A, Rodríguez M, Calleja J, Ramírez J. Función cognitiva en pacientes con diabetes mellitus tipo 2: correlación metabólica y por imagen de resonancia magnética. Med Int Mex 2011;27:217-223.

  28. Mejía-Arango S, Zúñiga-Gil C. Diabetes mellitus como factor de riesgo de demencia en la población adulta mayor mexicana. Rev Neurol 2001;53:397-405.

  29. Xu W, Qiu Ch, Winblad B, Fratiglioni L. The effect of borderline diabetes on the risk of dementia and Alzheimer disease. Diabetes 2007;56:211-215.

  30. Díaz de León E, Barrágan A, Gutiérrez H, Cobos H. Desempeño cognoscitivo y mortalidad en personas mayores de 50 años en México. Rev Panam Salud Pública 2010;27:368-375.

  31. Arvanitakis Z, Wilson R, Li Y, Thanik N et al. Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care 2006;29:560-565.

  32. Zihl J, Schaaf L, Zillmer E. The relationship between adult neuropsychological profiles and diabetic patient´s glycemic control. Appl Neuropsychol 2010;17:44-51.

  33. Aberle I, Kliegel M, Zimprich D. Cognitive development in Youngold type 2 diabetes patients: a longitudinal analysis from the “Interdisciplinary longitudinal study of aging”. Curr Psychol 2008;27:6-15.

  34. Yeung S, Fischer A, Dixon R. Exploring effects of type 2 diabetes on cognitive functioning in older adults. Neuropsychol 2009;23:1-9.

  35. Ryan C, Geckle M. Circumscribed cognitive dysfunction in middleaged adults with type 2 diabetes. Diabetes Care 2000;23:1486-1493.

  36. Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes and cognitive function. J Clin Exp Neuropsychol 2004;26:1044-1080.

  37. McAulay V, Deary I, Ferguson S, Frier B. Acute hypoglycemia in humans causes attentional dysfunction while nonverbal intelligence is preserved. Diabetes Care 2001;24:1745-1750.

  38. Galanina N, Surampudi V, Ciltea D, Singh S et al. Blood glucose levels before and after cognitive testing in diabetes mellitus. Exp Aging Res 2008;34:152-161.

  39. Décary A, Vendette M, Massicotte J, Mathieu A. A preliminary study of the impact of age-related pathologies on cognitive functioning and waking EEG. N Am J Psychol 2005;7:469-480.

  40. Bruce D, Davis W, Casey G, Starstein S et al. Predictors of cognitive decline in older individuals with diabetes. Diabetes Care 2008;31:2103-2107.

  41. Hassing L, Hofer S, Nilsson S, Berg S et al. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 2004;33:355-361.

  42. Ryan C. Diabetes and brain damage: more (or less) than meets the eye? Diabetologia 2006;49:2229-2233.

  43. Suzuki M, Umegaki H, Uno T, Oyun O et al. Association between insulin resistance and cognitive function in elderly diabetic patients. Geriatr Gerontol Int 2006;6:254-259.

  44. Greenwood C, Kaplan R, Hebblethwaite S. Carbohydrate-induced memory impairment in adults with type 2 diabetes. Diabetes Care 2003;26:1961-1966.

  45. Papanikolaou Y, Palmer H, Binns M, Jenkins D et al. Better cognitive performance following a low-glycaemic-index compared with a highglycaemic- index carbohydrate meal in adults with type 2 diabetes. Diabetologia 2006;49:855-862.

  46. Devore E, Stampfer M, Breteler M, Rosner B. Dietary fat intake and cognitive decline in women type 2 diabetes. Diabetes Care 2009;32:635-640.

  47. Llewellyn D, Lang I, Langa K, Muniz G et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010;170:1135-1140.

  48. NO Brito G. Exercise and cognitive function: a hypothesis for the association of type II diabetes mellitus and Alzheimer´s disease from an evolutionary perspective. Diabetol Metab Syndr 2009;1:1-7.

  49. Colberg S, Somma T, Sechrist S. Physical activity participation may offset some of the negative impact of diabetes on cognitive function. J Am Med Dir Assoc 2008;9:434-438.

  50. Indelicato J. Association between executive function, physical activity, and physical fitness in people with type 2 diabetes. USA: Northeastern University; 2009.




2020     |     www.medigraphic.com